Evidence map›Paper›PMID 37880231›Full record

ArticleNature communications2023

Single-atom catalysts-based catalytic ROS clearance for efficient psoriasis treatment and relapse prevention via restoring ESR1.

Xiangyu Lu, Le Kuai, Fang Huang, Jingsi Jiang, Jiankun Song, Yiqiong Liu, Si Chen, Lijie Mao, Wei Peng, Ying Luo and 4 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed, 1 pooled it
10.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 1 synthesis or guideline pooled it, 114 citations in OpenAlex.

  1. Sex Hormones in Psoriatic Disease: A Systematic Review.American journal of clinical dermatology · 2026
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Keratinocytes: pleiotropic orchestrators of cutaneous immunity and Inflammation - Emerging therapeutic paradigms in dermatological pathologies.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Xiangyu Lu *Shanghai Tenth People's Hospital, Shanghai Frontiers Science Center of Nanocatalytic Medicine, Clinical Center For Brain And Spinal Cord Research, School of Medicine, Tongji University, Shanghai, 200092, China.ORCID http://orcid.org/0000-0002-5606-894X
Le Kuai *Department of Dermatology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200437, China.
Fang Huang *Shanghai Tenth People's Hospital, Shanghai Frontiers Science Center of Nanocatalytic Medicine, Clinical Center For Brain And Spinal Cord Research, School of Medicine, Tongji University, Shanghai, 200092, China.
Jingsi JiangShanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai, 200443, China.
Jiankun SongShanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai, 200443, China.
Yiqiong LiuShanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai, 200443, China.
Si ChenShanghai Tenth People's Hospital, Shanghai Frontiers Science Center of Nanocatalytic Medicine, Clinical Center For Brain And Spinal Cord Research, School of Medicine, Tongji University, Shanghai, 200092, China.
Lijie MaoShanghai Tenth People's Hospital, Shanghai Frontiers Science Center of Nanocatalytic Medicine, Clinical Center For Brain And Spinal Cord Research, School of Medicine, Tongji University, Shanghai, 200092, China.
Wei PengInstitute of Waste Treatment and Reclamation, College of Environment Science and Engineering, Tongji University, Shanghai, 200092, China.
Ying LuoDepartment of Dermatology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200437, China.
Yongyong LiShanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai, 200443, China.
Haiqing DongKey Laboratory of Spine and Spinal Cord Injury Repair and Regeneration, Ministry of Education, Tongji Hospital, School of Medicine, Tongji University, Shanghai, 200065, China. inano_donghq@tongji.edu.cn.
Bin LiInstitute of Dermatology, Shanghai Academy of Traditional Chinese Medicine, Shanghai, 201203, China. lib@shskin.com.
Jianlin ShiShanghai Tenth People's Hospital, Shanghai Frontiers Science Center of Nanocatalytic Medicine, Clinical Center For Brain And Spinal Cord Research, School of Medicine, Tongji University, Shanghai, 200092, China. jlshi@mail.sic.ac.cn.ORCID http://orcid.org/0000-0001-8790-195X
Tongji University · CNShanghai University of Traditional Chinese Medicine · CNChinese Academy of Sciences · CNShanghai Institute of Applied Physics · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Psoriasis is a common inflammatory disease of especially high recurrence rate (90%) which is suffered by approximately 3% of the world population. The overexpression of reactive oxygen species (ROS) plays a critical role in psoriasis progress. Here we show that biomimetic iron single-atom catalysts (FeN

Indexed as

Estrogen Receptor alphaPsoriasisHumansReactive Oxygen SpeciesSecondary PreventionSuperoxide DismutaseEstrogen Receptor alphaReactive Oxygen SpeciesSuperoxide Dismutase

Identifiers

PMID37880231
PMCPMC10600197
OpenAlexW4387939835

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.